Aerospace & Defense (A&D) is an Industrials sub-sector that bundles two businesses with fundamentally different demand drivers under one GICS label. Commercial aerospace sells and services airliners, engines, and parts — its demand follows airline profitability, passenger traffic, and fleet-renewal cycles, so it is genuinely cyclical. Defense sells weapons systems and services to governments — its demand follows national-security budgets and multi-year procurement programs, so it behaves more like a policy-driven annuity than a business cycle. The core tension for an analyst is that a single ticker (e.g. Boeing, RTX) often straddles both, and the two halves want to be valued on completely different logic. Treating A&D as one homogeneous "sector" is the most common framing error.

How the industry is structured

Commercial aerospace is anchored by the Airbus–Boeing duopoly at the large-jet level, supported by engine makers (GE Aerospace, Safran, RR, Pratt & Whitney), tier-1/2 suppliers, and a large aftermarket (MRO — maintenance, repair, overhaul). A counterintuitive but well-documented economic reality: selling new aircraft is low-margin to value-destructive, while the aftermarket is where the money is. Industry analysis (BCG, Aviation Week) consistently finds aftermarket margins run several times higher than new-equipment margins (commonly cited multiples range from roughly 2x to 4x; e.g. spare parts at ~30–50% gross vs ~15–25% on new units), and engine OEMs deliberately sell engines near cost to capture decades of high-margin service revenue — the classic "razor-and-blades" model. This is why the installed base and service mix matter more than headline order counts for many suppliers.

Defense is dominated by a small set of US "primes" — Lockheed Martin, RTX, Northrop Grumman, General Dynamics, plus L3Harris and Boeing's defense unit — selling to a near-monopsony customer (governments). Revenue concentration in a single customer is structural, not a flaw: for several primes, US-government contracts approach or exceed a third of revenue.

The metrics that actually matter

• Backlog and book-to-bill. Backlog is unfilled orders; book-to-bill = new orders ÷ revenue billed in the period. >1.0 means the order book is growing. Commercial OEM backlogs commonly span 7–10 years of production; defense backlogs are shorter but extend visibility well beyond one year. Industry commentary notes airframers often target book-to-bill well above 1, while defense names cluster nearer 1–2. Backlog is the sector's signature feature — it gives revenue visibility rare in Industrials — but backlog is not cash; cancellations, delivery slips, and inflation on fixed-price work all erode it.
• Contract type (defense). Cost-plus contracts reimburse cost plus a negotiated fee (commonly cited around 8–12%); margin is capped but losses are nearly impossible, and the structure can perversely reward delay. Fixed-price contracts pay a set amount; margin is uncapped on the upside but the contractor eats overruns. Fixed-price development programs have been the sector's biggest margin landmine — Boeing disclosed roughly $4.9 billion of losses on fixed-price defense programs in 2024 (per company filings and reporting). Always check the cost-plus / fixed-price mix.
• Free cash flow & deliveries. For commercial OEMs, FCF is delivery-driven and lumpy; aircraft build cash before delivery, so production-rate stumbles hit cash hard (Boeing reported roughly negative ~$1.9B FCF for FY2025, per reporting). Deliveries, not orders, convert backlog to cash.

How it's used in practice

Analysts and allocators typically split the sector before valuing it. Defense primes are treated as low-beta, dividend-compounding, backlog-backed quasi-utilities — Breaking Defense and trade press note the primes' explicit commitments to dividends, and one diversified A&D name is cited with a ~35-year dividend-increase streak and beta near 0.34. Commercial aerospace and cyclical suppliers are traded more on the airline cycle, traffic recovery, and production-rate inflections. Common positioning frameworks (e.g. Motley Fool, sector strategists) suggest core holdings in one or two primes for income/visibility, smaller tactical exposure to higher-beta names (drones, space, suppliers), and the iShares U.S. Aerospace & Defense ETF (ITA) or SPDR S&P Aerospace & Defense ETF (XAR) for diffuse sector beta — noting ITA is market-cap weighted (prime-heavy) while XAR is more equal-weighted (more supplier/mid-cap tilt).

Adoption, debate & evidence

The framing genuinely in dispute right now is "is defense still cyclical?" A wave of 2025–2026 sell-side and asset-manager pieces (Artisan Partners, Dividend.com, Deloitte) argue defense has shifted from cyclical to structural growth, citing global defense budgets above ~$2.8tn and decade-long backlogs. The bull case is real but it is a narrative-driven re-rating, and the honest caveat is valuation: multiple sources note the big primes traded around ~22–25x forward earnings, a premium to both the S&P 500 and their own ~10-year averages — meaning the backlog/visibility story is substantially priced in, leaving a thin margin of safety. Lockheed has at times been the cheaper exception (~17x). The countervailing risk that the "structural" thesis underweights: defense is ultimately exposed to budget/political cycles (continuing resolutions, debt-ceiling fights, administration priorities, foreign-policy shifts), and any of these can stall the procurement that the multiple assumes.

Strengths & limitations

When the sector works: high barriers to entry (certification, classified clearances, sole-source programs), sticky multi-decade installed bases, backlog visibility, and — for defense — a counter-cyclical, recession-resistant government customer. Defense names historically offer low beta and reliable dividends.

When it fails: (1) Fixed-price development losses — the single most damaging recurring failure mode, where a contractor underbids a hard technical program and absorbs years of overruns. (2) Production/supply-chain breakdown in commercial — backlog is worthless if you can't build and deliver; the post-COVID supply chain and Boeing's quality crises are case studies. (3) Program/customer concentration — losing or having a flagship program cut (e.g. a contract recompete) can dent the whole thesis. (4) Valuation — buying the visibility story at a cycle-high multiple.

The #1 misuse: valuing a mixed-model A&D company on a single multiple, or assuming "defense = safe" without checking the contract mix and how much of the structural-growth re-rating is already in the price.

Sources

• Deloitte — 2026 Aerospace and Defense Industry Outlook (budget/backlog landscape)
• Artisan Partners — Aerospace & Defense: From Cyclical Exposure to Structural Growth; Dividend.com — Global Defense and Aerospace: A Structural Growth Story (cyclical→structural debate)
• BCG — Can Airplane OEMs Increase Their Share of Profits?; Aviation Week — Commercial Aerospace Has a Profit Problem (aftermarket vs OEM margins, ~2–4x range)
• AnalystInterview — Aerospace and Defense Order Backlog to Revenue Ratio (book-to-bill conventions)
• IB Interview Questions — Defense Contract Types: Cost-Plus, Fixed-Price, and Their Impact on Margins; Breaking Defense — The 'Cost Plus' boondoggle (contract economics, fee ranges, Boeing $4.9B fixed-price loss)
• The Motley Fool — Lockheed Martin vs. Boeing 2026; Best Defense Stocks; Breaking Defense / Air & Space Forces — primes' dividend commitments (valuation multiples ~22–25x, dividends, low beta, ITA framing)
• Reporting on Boeing FY2025 FCF (~ -$1.9B) — cross-checked against multiple market summaries
• Flag: forward-multiple, FCF, and budget figures are point-in-time (2025–2026) and drift; verify current data before acting. The "defense is no longer cyclical" claim is a contested narrative, not settled fact.